ArticlePloS one2017

Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice.

Fangfang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.